| Trial ID: | L4680 |
| Source ID: | NCT01751321
|
| Associated Drug: |
Sitagliptin, Placebo
|
| Title: |
Glucose Variability With DPP-4 Inhibition
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Sitagliptin, placebo
|
| Outcome Measures: |
Primary: glucose variability, 1 month |
|
| Sponsor/Collaborators: |
Sponsor: Research Clinical Centre of the Russian Railways, JSC
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: |Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2013-05
|
| Completion Date: |
2013-10
|
| Results First Posted: |
|
| Last Update Posted: |
2012-12-17
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01751321
|
